Bloomberg News

BioCancell Cancer Treatment Wins ‘Fast Track’ Status From FDA

October 04, 2011

Oct. 4 (Bloomberg) -- BioCancell Therapeutics Inc. said the U.S. Food and Drug Administration gave its BC-819 pancreatic- cancer treatment “fast track” status. BioCancell made the announcement in an e-mailed statement.

To contact the reporter on this story: Gwen Ackerman in Jerusalem at gackerman@bloomberg.net

To contact the editor responsible for this story: Shoshanna Solomon at ssolomon22@bloomberg.net


Race, Class, and the Future of Ferguson
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus